A Convergent Total Synthesis of the Michellamines

A convergent total synthesis of the anti-HIV michellamines (1) is described. The tetraaryl skeleton of the michellamines was constructed by formation first of the inner (nonstereogenic) biaryl axis and subsequently of the two other (stereogenic) axes in a highly convergent manner. The key transforma...

Full description

Saved in:
Bibliographic Details
Published inJournal of organic chemistry Vol. 63; no. 4; pp. 1090 - 1097
Main Authors Bringmann, Gerhard, Götz, Roland, Keller, Paul A, Walter, Rainer, Boyd, Michael R, Lang, Fengrui, Garcia, Alberto, Walsh, John J, Tellitu, Imanol, Bhaskar, K. Vijaya, Kelly, T. Ross
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 20.02.1998
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A convergent total synthesis of the anti-HIV michellamines (1) is described. The tetraaryl skeleton of the michellamines was constructed by formation first of the inner (nonstereogenic) biaryl axis and subsequently of the two other (stereogenic) axes in a highly convergent manner. The key transformation features a double Suzuki-type cross-coupling reaction between binaphthalene ditriflate 26 and isoquinolineboronic acid 35. Ditriflate 26 is synthesized in six steps starting from diene 6 and 2,6-dibromobenzoquinone (9) in 21% overall yield. For large scale production of 26, a substantially shortened version of an existing procedure for the preparation of bisnaphthoquinone 13 was also developed, which allows for the preparation of 13 from benzoquinone and diene 6 in five steps and 67% overall yield. Binaphthoquinone 13 was subsequently converted into ditriflate 26 in three steps and 67% overall yield. By the described synthetic strategy, michellamines A (1a) and B (1b) are produced (1a:1b = 1:2.5) in 24.6% overall yield from diene 6. Curiously, none of the nonnaturally occurring atropoisomer 1c is formed.
Bibliography:Part 102 in the series Acetogenic Naphthylisoquinoline Alkaloids (from the University of Würzburg). For part 101, see:  Bringmann, G.; Saeb, W.; Wenzel, M.; François, G.; Schlauer, J. Pharm. Pharmacol. Lett., submitted. Part 47 in the series:  HIV-Inhibitory Natural Products (from the National Cancer Institute). For part 46, see:  Hallock, Y. F.; Cardellina, J. H., II; Schäffer, M.; Bringmann, G.; Boyd, M. R. BioMed. Chem. Lett., submitted.
istex:33C712C928AB54850D8CE311088351721AD85A58
ark:/67375/TPS-6M5WP2PM-G
ISSN:0022-3263
1520-6904
DOI:10.1021/jo971495m